Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $18.9700 (-4%) ($18.2000 - $19.8500) on Mon. Oct. 21, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.09% (three month average) | RSI | 60 | Latest Price | $18.9700(-4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -2.1% a day on average for past five trading days. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) IFRA(28%) QQQ(28%) XLC(26%) TBT(25%) IBB(24%) | Factors Impacting SONN price | SONN will decline at least -3.045% in a week (0% probabilities). VCSH(-35%) TLT(-28%) LQD(-27%) CEMB(-26%) VCIT(-20%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.045% (StdDev 6.09%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $19.96 | 5 Day Moving Average | $20.02(-5.24%) | 10 Day Moving Average | $20.62(-8%) | 20 Day Moving Average | $19.96(-4.96%) | To recent high | -15.2% | To recent low | 43.1% | Market Cap | $175m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |